Standard MRI scans for esophageal cancer before surgery
Part of Cancer, Digestive system clinical trials.
This study looks at using a standardized MRI scan (a detailed imaging test) and structured reporting to better evaluate esophageal squamous cell carcinoma before surgery. The goal is to improve how doctors plan and assess treatment, potentially leading to more precise surgery and better outcomes for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- A biopsy confirmed you have a type of esophageal cancer called squamous cell carcinoma.
- The cancer is in the middle or lower part of the esophagus, not the neck or stomach.
- You are able to have an MRI scan (including contrast dye) with good image quality.
- You are scheduled to have surgery to remove the cancer.
- Depending on the study group, you either have had no anti-cancer treatment before the MRI, or you are receiving chemotherapy/radiation before surgery and will have an MRI before and after that treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of three medicines (immunotherapy plus two chemotherapy drugs) given before surgery to shrink esophageal cancer. The goal is to make the tumor smaller and easier to remove completely, potentially improving the chance of a cure.
This trial tests a combination of low-dose radiation, chemotherapy, and immunotherapy before surgery for esophageal cancer. The goal is to see if this approach helps shrink the tumor and improve outcomes.
This trial tests a combination of two targeted drugs (nimotuzumab and camrelizumab) plus standard chemotherapy before surgery for people with esophageal squamous cell carcinoma. The goal is to see if this approach helps shrink the tumor and improve outcomes.
This study looks at whether CT and MRI scans taken before and after chemotherapy or radiation can help doctors predict how well the treatment is working and what the cancer looks like after surgery. It may help improve treatment plans for people with esophageal cancer.
This Phase 1 study uses specialized imaging (including MRI) to better “see” low-oxygen areas in esophageal cancer and help guide individualized radiation treatment. It aims to improve how radiation is planned and delivered while checking safety.
This study checks whether MRI and CT scans can better measure how esophageal or stomach-junction tumors respond during chemoradiotherapy and help doctors map the exact treatment area. It may help improve targeting while you receive standard treatment.
Hear when a new Esophageal Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.